Read Time:9 Second
Biocon Limited has informed the Exchange regarding a press release dated December 13, 2025, titled “Biocon Biologics Signs Settlement and License Agreement to Commercialize Biosimilar Aflibercept Worldwide”. |SUBJECT: Press Release
Happy
0
0 %
Sad
0
0 %
Excited
0
0 %
Sleepy
0
0 %
Angry
0
0 %
Surprise
0
0 %
